CN101703813B - 利用内源性no供体构建抗凝血性血管支架材料的方法 - Google Patents
利用内源性no供体构建抗凝血性血管支架材料的方法 Download PDFInfo
- Publication number
- CN101703813B CN101703813B CN2009102287062A CN200910228706A CN101703813B CN 101703813 B CN101703813 B CN 101703813B CN 2009102287062 A CN2009102287062 A CN 2009102287062A CN 200910228706 A CN200910228706 A CN 200910228706A CN 101703813 B CN101703813 B CN 101703813B
- Authority
- CN
- China
- Prior art keywords
- blood vessel
- layer
- donor
- high polymer
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004204 blood vessel Anatomy 0.000 title claims abstract description 39
- 238000000034 method Methods 0.000 title claims abstract description 34
- 239000008280 blood Substances 0.000 title claims abstract description 19
- 239000002840 nitric oxide donor Substances 0.000 title claims abstract description 19
- 230000015271 coagulation Effects 0.000 title claims abstract description 12
- 238000005345 coagulation Methods 0.000 title claims abstract description 12
- 239000000463 material Substances 0.000 claims abstract description 36
- 229920000642 polymer Polymers 0.000 claims abstract description 23
- 239000002473 artificial blood Substances 0.000 claims abstract description 13
- 229920000447 polyanionic polymer Polymers 0.000 claims abstract description 9
- 210000004369 blood Anatomy 0.000 claims abstract description 7
- 229920000620 organic polymer Polymers 0.000 claims abstract description 5
- 230000001105 regulatory effect Effects 0.000 claims abstract description 5
- 239000002184 metal Substances 0.000 claims abstract description 3
- 230000002792 vascular Effects 0.000 claims description 13
- 229920002643 polyglutamic acid Polymers 0.000 claims description 10
- 108010020346 Polyglutamic Acid Proteins 0.000 claims description 9
- 239000002120 nanofilm Substances 0.000 claims description 8
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 229920001610 polycaprolactone Polymers 0.000 claims description 6
- 239000004632 polycaprolactone Substances 0.000 claims description 6
- 108010039918 Polylysine Proteins 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 claims description 5
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 5
- 229920000903 polyhydroxyalkanoate Polymers 0.000 claims description 5
- 239000004626 polylactic acid Substances 0.000 claims description 5
- 229920000656 polylysine Polymers 0.000 claims description 5
- 238000001179 sorption measurement Methods 0.000 claims description 5
- 229920001661 Chitosan Polymers 0.000 claims description 4
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- 229960001126 alginic acid Drugs 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 239000000783 alginic acid Substances 0.000 claims description 3
- 150000004781 alginic acids Chemical class 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 238000000861 blow drying Methods 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 229920000669 heparin Polymers 0.000 claims description 3
- 229960002897 heparin Drugs 0.000 claims description 3
- 238000001338 self-assembly Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 230000001413 cellular effect Effects 0.000 claims 1
- 229920001577 copolymer Polymers 0.000 claims 1
- 239000011669 selenium Substances 0.000 abstract description 6
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract description 3
- 229910052711 selenium Inorganic materials 0.000 abstract description 3
- 230000023555 blood coagulation Effects 0.000 abstract description 2
- 230000001276 controlling effect Effects 0.000 abstract 2
- HYHSBSXUHZOYLX-WDSKDSINSA-N S-nitrosoglutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CSN=O)C(=O)NCC(O)=O HYHSBSXUHZOYLX-WDSKDSINSA-N 0.000 abstract 1
- 230000002459 sustained effect Effects 0.000 abstract 1
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 40
- 230000002429 anti-coagulating effect Effects 0.000 description 7
- 239000003146 anticoagulant agent Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 5
- 208000007536 Thrombosis Diseases 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 229940127219 anticoagulant drug Drugs 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000003725 endotheliocyte Anatomy 0.000 description 3
- 102000006587 Glutathione peroxidase Human genes 0.000 description 2
- 108700016172 Glutathione peroxidases Proteins 0.000 description 2
- 239000007987 MES buffer Substances 0.000 description 2
- NJSSICCENMLTKO-HRCBOCMUSA-N [(1r,2s,4r,5r)-3-hydroxy-4-(4-methylphenyl)sulfonyloxy-6,8-dioxabicyclo[3.2.1]octan-2-yl] 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)O[C@H]1C(O)[C@@H](OS(=O)(=O)C=2C=CC(C)=CC=2)[C@@H]2OC[C@H]1O2 NJSSICCENMLTKO-HRCBOCMUSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 230000000702 anti-platelet effect Effects 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 230000010100 anticoagulation Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- XIMIGUBYDJDCKI-UHFFFAOYSA-N diselenium Chemical compound [Se]=[Se] XIMIGUBYDJDCKI-UHFFFAOYSA-N 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000001095 inductively coupled plasma mass spectrometry Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical group CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 229920000867 polyelectrolyte Polymers 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 208000037803 restenosis Diseases 0.000 description 2
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- MKWKNSIESPFAQN-UHFFFAOYSA-N N-cyclohexyl-2-aminoethanesulfonic acid Chemical compound OS(=O)(=O)CCNC1CCCCC1 MKWKNSIESPFAQN-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000006177 biological buffer Substances 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000010041 electrostatic spinning Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002715 modification method Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000010118 platelet activation Effects 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000000250 revascularization Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- ICRHORQIUXBEPA-UHFFFAOYSA-N thionitrous acid Chemical compound SN=O ICRHORQIUXBEPA-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 230000002227 vasoactive effect Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102287062A CN101703813B (zh) | 2009-11-25 | 2009-11-25 | 利用内源性no供体构建抗凝血性血管支架材料的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102287062A CN101703813B (zh) | 2009-11-25 | 2009-11-25 | 利用内源性no供体构建抗凝血性血管支架材料的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101703813A CN101703813A (zh) | 2010-05-12 |
CN101703813B true CN101703813B (zh) | 2012-11-28 |
Family
ID=42374108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009102287062A Active CN101703813B (zh) | 2009-11-25 | 2009-11-25 | 利用内源性no供体构建抗凝血性血管支架材料的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101703813B (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102441192B (zh) * | 2011-09-30 | 2014-08-27 | 上海交通大学 | 基因释放型支架及其制备方法 |
CN104955468A (zh) * | 2013-01-21 | 2015-09-30 | 协和发酵生化株式会社 | 一氧化氮浓度增高剂 |
CA2912664C (en) * | 2013-05-20 | 2022-07-26 | Yale University | Anti-thrombogenic grafts |
CN103330960A (zh) * | 2013-06-26 | 2013-10-02 | 西南交通大学 | 一种具有内皮仿生功能涂层的制备方法 |
KR101555523B1 (ko) * | 2014-02-28 | 2015-09-25 | 부산대학교 산학협력단 | 산화질소 방출성 상처치료 필름 및 이의 제조방법 |
CN104673096B (zh) * | 2014-08-12 | 2017-05-17 | 西南交通大学 | 一种具有一氧化氮(no)催化活性的涂层的制备方法 |
CN104208761B (zh) * | 2014-08-12 | 2015-11-25 | 西南交通大学 | 一种具有诱导催化内源性no释放功能的抗凝血材料制备方法 |
CN104225675B (zh) * | 2014-08-12 | 2016-10-05 | 西南交通大学 | 一种具有一氧化氮(no)催化活性的材料的制备方法 |
CN104208760B (zh) * | 2014-08-12 | 2016-08-17 | 西南交通大学 | 一种铜离子介导的具有原位催化no释放功能的抗凝血涂层制备方法 |
CN104307053B (zh) * | 2014-10-11 | 2015-11-25 | 西南交通大学 | 一种表面具有l-手征性的催化活性多功能生物活性涂层的制备方法 |
CN106267369B (zh) * | 2016-08-05 | 2019-05-31 | 华中科技大学同济医学院附属协和医院 | 一种人造血管及其制备方法 |
CN111603616B (zh) * | 2020-06-04 | 2021-04-30 | 青岛大学 | 具有双药负载和分阶缓释功能的纳米纤维血管支架材料及其制备方法 |
CN115212350B (zh) * | 2021-04-14 | 2024-02-13 | 南京师范大学 | 水凝胶在制备高仿生人造血管材料中的应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004112863A1 (en) * | 2003-06-20 | 2004-12-29 | Mcgill University | Biodegradable membrane-covered implant comprising chitosan |
CN1806857A (zh) * | 2005-01-17 | 2006-07-26 | 李庆范 | 药物释放调节型多层涂层支架及其制造方法 |
CN1911459A (zh) * | 2006-08-18 | 2007-02-14 | 天津百畅医疗器械科技有限公司 | 可缓解缺血再灌注后自由基对细胞损伤的血管支架药物涂层 |
-
2009
- 2009-11-25 CN CN2009102287062A patent/CN101703813B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004112863A1 (en) * | 2003-06-20 | 2004-12-29 | Mcgill University | Biodegradable membrane-covered implant comprising chitosan |
CN1806857A (zh) * | 2005-01-17 | 2006-07-26 | 李庆范 | 药物释放调节型多层涂层支架及其制造方法 |
CN1911459A (zh) * | 2006-08-18 | 2007-02-14 | 天津百畅医疗器械科技有限公司 | 可缓解缺血再灌注后自由基对细胞损伤的血管支架药物涂层 |
Also Published As
Publication number | Publication date |
---|---|
CN101703813A (zh) | 2010-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101703813B (zh) | 利用内源性no供体构建抗凝血性血管支架材料的方法 | |
CN108785748B (zh) | 一种具有超亲水性能的多功能心血管涂层材料及其制备方法 | |
Wang et al. | Functional modification of electrospun poly (ε-caprolactone) vascular grafts with the fusion protein VEGF–HGFI enhanced vascular regeneration | |
Zisch et al. | Biopolymeric delivery matrices for angiogenic growth factors | |
US8303972B2 (en) | Hydrogel bioscaffoldings and biomedical device coatings | |
Xue et al. | Biomaterials in the development and future of vascular grafts | |
JP5722033B2 (ja) | 接着分子のグラフト鎖を共有結合させて変性したコラーゲンスキャフォールドと、その収縮細胞の組織工学および胸部及び心臓血管治療への応用 | |
US8828433B2 (en) | Hydrogel bioscaffoldings and biomedical device coatings | |
JP5139301B2 (ja) | 生分解性天然多糖を含む被膜及び器具 | |
Waterhouse et al. | Elastin as a nonthrombogenic biomaterial | |
Andukuri et al. | Effect of endothelium mimicking self-assembled nanomatrices on cell adhesion and spreading of human endothelial cells and smooth muscle cells | |
US6921811B2 (en) | Bioactive coating composition and methods | |
US7709439B2 (en) | Biomaterials for enhanced healing | |
Wise et al. | Engineered tropoelastin and elastin-based biomaterials | |
Tang et al. | Regulation of macrophage polarization and promotion of endothelialization by NO generating and PEG-YIGSR modified vascular graft | |
JP2004505124A (ja) | 生物活性被覆組成物と方法 | |
Bai et al. | Biofunctionalized electrospun PCL‐PIBMD/SF vascular grafts with PEG and cell‐adhesive peptides for endothelialization | |
JP2007537005A (ja) | 医療用具のための天然生分解性多糖コーティング | |
CN108815552A (zh) | 一种多药物可控装载及长效缓释的生物医用涂层材料及其制备方法 | |
Santos et al. | In vivo short-term and long-term host reaction to starch-based scaffolds | |
US20180263751A1 (en) | Post-surgical healing accelerator | |
Joshy et al. | Plasma modified polymeric materials for scaffolding of bone tissue engineering | |
Wang et al. | Thermo-triggered ultrafast self-healing of microporous coating for on-demand encapsulation of biomacromolecules | |
Martin et al. | Oxidation‐responsive, tunable growth factor delivery from polyelectrolyte‐coated implants | |
ES2784924T3 (es) | Dispositivos médicos con trombogenicidad reducida |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191220 Address after: 211100 building 11, Jiyin Jiahe, No. 998, qingshuiting East Road, Jiangning District, Nanjing City, Jiangsu Province Patentee after: Jiangsu Wancheng Biomedical Research Institute Address before: 300071 Tianjin City, Nankai District Wei Jin Road No. 94 Patentee before: Nankai University |
|
TR01 | Transfer of patent right | ||
DD01 | Delivery of document by public notice |
Addressee: JIANGSU WANCHENG BIOMEDICAL RESEARCH INSTITUTE Co.,Ltd. Person in charge of patents Document name: payment instructions |
|
DD01 | Delivery of document by public notice |